header-logo header-logo

23 September 2016
Issue: 7715 / Categories: Case law , Law digest , In Court
printer mail-detail

EU

Sun Pharmaceuticals Industries Ltd and another company v European Commission T-460/13, [2016] All ER (D) 52 (Sep)

The General Court of the European Union dismissed the application by Sun Pharmaceuticals Industries Ltd (formerly Ranbaxy Laboratories Ltd) and Ranbaxy (UK) Ltd for annulment in part of Commission Decision C(2013) 3803 final of 19 June 2013 relating to a proceeding under Art 101 of the Treaty on the Functioning of the European Union and Art 53 of the European Economic Area Agreement and for reduction of the amount of the fine imposed on those companies by that decision. The General Court held that none of the pleas in law relied on by them in support of their application was well founded.

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Signature Litigation—Catherine Naylor

Signature Litigation—Catherine Naylor

International fraud and asset recovery offering boosted by partner hire

Stevens & Bolton—Alexa Payet

Stevens & Bolton—Alexa Payet

Private wealth disputes team adds contentious probate specialist

Morgan Lewis—Paul Feldberg

Morgan Lewis—Paul Feldberg

Firm strengthens investigations and sanctions capabilities with London partner hire

NEWS
Cheshire West, which established an ‘acid test’ for deprivation of liberty safeguards, has been overturned by the Supreme Court
The Chancery Division and other segments of the High Court are to be replaced by a new Business and Property Division (BPD), in a major civil justice shakeup
Law firms that hold client money will need to file annual accountants’ reports and make a declaration, the Solicitors Regulation Authority (SRA) confirmed this week
Two district judges and a tribunal judge have been sanctioned for delays in delivering judgments and orders
Private equity (PE) investment into UK law firms halved to £250m last year, but deal volume rose, according to research by Acquira Professional Services’ Momentum private equity market tracker
back-to-top-scroll